ArticleCirculation2020

Response by Kazi et al to Letter Regarding Article, "Cost-Effectiveness of Tafamidis Therapy for Transthyretin Amyloid Cardiomyopathy".

Dhruv S Kazi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.